CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at $45.22 ($904,424)
- 4 Open-market sale Director and CEO, Alkermes plc sold 20,000 shares at an average $45.46 ($909,163)
- 4 Exercise or conversion SVP, CLO, Alkermes, Inc. acquired 275 shares (option exercise)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 20,000 shares at an average $46.14 ($922,846)
- 4 Open-market sale Director and CEO, Alkermes plc sold 50,000 shares at $46.38 ($2,319,100)
- 4 Open-market sale Director and CEO, Alkermes plc sold 50,000 shares at an average $44.32 ($2,215,775)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 26 of 67 · 1,323 filings